Practice Parameter: Recurrent stroke with patent foramen ovale and atrial septal aneurysm. Report of the Quality Standards Subcommittee of the American Academy of Neurology

Neurology

Volumn 62, Issue 7, 2004, Pages 1042-1050

  Messe S R ^a   Silverman, I E ^b   Kizer, J R ^c   Homma, S ^d   Zahn, C ^e   Gronseth, G ^f   Kasner, S E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HARTFORD HOSPITAL   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e TORONTO WESTERN HOSPITAL   (Canada)

^f UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ANEURYSM; ANTICOAGULATION; ATRIAL SEPTAL ANEURYSM; BLEEDING; CAUSE OF DEATH; CLINICAL TRIAL; COCHRANE LIBRARY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOVASCULAR SURGERY; HEART ATRIUM SEPTUM DEFECT; HUMAN; MEDICAL SOCIETY; PRIORITY JOURNAL; PROGNOSIS; QUALITY CONTROL; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; STANDARD; STROKE; TREATMENT OUTCOME;

EID: 1842528129     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000119173.15878.F3     Document Type: Review

References (37)

1. Kerut EK, Norfleet WT, Plotnick GD, Giles TD. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol 2001;38:613-623.
2. Seib G. Incidence of the patent foramen ovale cordis in adult American whites and American Negroes. A J Anat 1934;55:511-525.
3. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17-20.
4. Meissner I, Whisnant JP, Khandheria BK, et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc 1999;74:862-869.
5. Schneider B, Harath P, Vogel P, Meinertz T. Improved morphologic characterization of atrial septal aneurysm by transesophageal echocardiography: relation to cerebrovascular events. J Am Coll Cardiol 1990; 16:1000-1009.
6. Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-1746.
7. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, PICSS Investigators. Relationship of atrial septal aneurysm with patent foramen ovale: insights from PFO in Cryptogenic Stroke Study (PICSS). Circulation 2001;104(suppl II):670. Abstract.
8. Fox ER, Picard MH, Chow CM, Levine RA, Schwamm L, Kerr AJ. Interatrial septal mobility predicts larger shunts across patent foramen ovales: an analysis with transmitral Doppler scanning. Am Heart J 2003;145:730-736.
9. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Atrial anatomy in non-cardioembolic stroke patients: effect of medical therapy. J Am Coll Cardiol 2003;42:1066-1072.
10. Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TR. Infarcts of undetermined cause: the NINCDS stroke data bank. Ann Neurol 1989;25:382-390.
11. Webster MW, Chancellor AM, Smith HJ, et al. Patent foramen ovale in young stroke patients. Lancet 1988;2(8601):11-12.
12. Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-1152.
13. Pearson AC, Nagelhout D, Castello R, Gomez CR, Labovitz AJ. Atrial septal aneurysm and stroke: a transesophageal echocardiographic study. J Am Coll Cardiol 1991;18:1223-1229.
14. Cabanes L, Mas JL, Cohen A, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 1993;24:1865-1873.
15. Agmon Y, Khandheria BK, Meissner I, et al. Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation 1999; 99:1942-1944.
16. Mattioli AV, Aquilina M, Oldani A, Longhini C, Mattioli G. Atrial septal aneurysm as a cardioembolic source in adult patients with stroke and normal carotid arteries. A multicentre study. Eur Heart J 2001;22: 261-268.
17. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000;55: 1172-1179.
18. Homma S, Di Tullio MR, Sacco RL, Mihalatos D, Li Mandri G, Mohr JP. Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study. Stroke 1994;25:582-586.
19. Steiner MM, Di Tullio MR, Rundek T, et al. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 1998;29:944-948.
20. Serena J, Segura T, Perez-Ayuso MJ, Bassaganyas J, Molins A, Davalos A. The need to quantify right-to-left shunt in acute ischemic stroke: a case-control study. Stroke 1998;29:1322-1328.
21. De Castro S, Cartoni D, Fiorelli M, et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 2000;31:2407-2413.
22. Anzola GP, Zavarize P, Morandi E, Rozzini L, Parrinello G. Transcranial Doppler and risk of recurrence in patients with stroke and patent foramen ovale. Eur J Neurol 2003;10:129-135.
23. Rice MJ, McDonald RW, Reller MD. Fetal atrial septal aneurysm: a cause of fetal atrial arrhythmias. J Am Coll Cardiol 1988;12:1292-1297.
24. Berthet K, Lavergne T, Cohen A, et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke 2000;31:398.
25. Somody E, Albucher JF, Casteignau G, et al. Anomalies of the interatrial septum and latent atrial vulnerability in unexplained ischemic stroke in young adults. Arch Mal Coeur Vaiss 2000;93:1495-1500.
26. Di Tullio MR, Sacco RL, Sciacca RR, et al. Patent foramen ovale and risk of ischemic stroke in a community - The Northern Manhattan Study. Stroke 2003;34:1. Abstract.
27. Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G. Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Lausanne Stroke with Paradoxical Embolism Study Group. Neurology 1996;46:1301-1305.
28. Dearani JA, Baran US, Danielson GK, et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999;100(suppl II):II171-II175.
29. Homma S, Di Tullio MR, Sacco RL, Sciacca RR, Smith C, Mohr JP. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke 1997;28:2376-2381.
30. Windecker S, Wahl A, Chatterjee T. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation 2000;101:893-898.
31. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in cryptogenic stroke study. Circulation 2002;105:2625-2631.
32. Nedeltchev K, Arnold M, Wahl A, et al. Outcome of patients with cryptogenic stroke and patent foramen ovale. J Neurol Neurosurg Psychiatry 2002;72:347-350.
33. Hyers TM, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2001;119(1 suppl):176S-193S.
34. Van Camp G, Schulze D, Cosyns B, Vandenbossche JL. Relation between patent foramen ovale and unexplained stroke. Am J Cardiol 1993;71:596-598.
35. Stone DA, Godard J, Corretti MC, et al. Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events. Am Heart J 1996;131:158-161.
36. De Castro S, Cartoni D, Fiorelli M, et al. Patent foramen ovale and its embolic implications. Am J Cardiol 2000;86:51G-52G.
37. Natanzon A, Goldman ME. Patent foramen ovale: anatomy versus pathophysiology-which determines stroke risk? J Am Soc Echocardiogr 2003;16:71-76.